Clinical trial
IMPACT of Nebilet in Blood Pressure Control in Patients With HYpertension: An Observational, Longitudinal Study
NCT06938516 is registered in ClinicalTrials.gov with A.Menarini Asia-Pacific Holdings Pte Ltd as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- IMPACT of Nebilet in Blood Pressure Control in Patients With HYpertension: An Observational, Longitudinal Study
- Lead sponsor
- A.Menarini Asia-Pacific Holdings Pte Ltd
- Phase
- Observational
- Overall status
- Recruiting
- Start date
- December 20, 2023
- Completion date
- March 31, 2029
- Enrollment
- 4,537 (estimated)
- Sites
- 49
Conditions
As the registry lists them; a condition with its own page is linked.